These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3359700)

  • 1. Unexpected severe reversible cyclosporine A-induced nephrotoxicity in a patient with systemic lupus erythematosus and tubulointerstitial renal disease.
    ter Borg EJ; Tegzess AM; Kallenberg CG
    Clin Nephrol; 1988 Feb; 29(2):93-5. PubMed ID: 3359700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulointerstitial renal disease in systemic lupus erythematosus.
    O'Dell JR; Hays RC; Guggenheim SJ; Steigerwald JC
    Arch Intern Med; 1985 Nov; 145(11):1996-9. PubMed ID: 4062450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis.
    Mori Y; Kishimoto N; Yamahara H; Kijima Y; Nose A; Uchiyama-Tanaka Y; Fukui M; Kitamura T; Tokoro T; Masaki H; Nagata T; Umeda Y; Nishikawa M; Iwasaka T
    Clin Exp Nephrol; 2005 Mar; 9(1):79-84. PubMed ID: 15830279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of systemic lupus erythematosus in a patient receiving cyclosporine A.
    Makover D; Freundlich B; Zurier RB
    J Rheumatol; 1988 Jan; 15(1):117-9. PubMed ID: 3280791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
    Dreyling KW; Wanner C; Schollmeyer P
    Clin Nephrol; 1990 Apr; 33(4):179-83. PubMed ID: 2350905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus.
    Kur JK; Esdaile JM
    J Rheumatol; 2006 Nov; 33(11):2178-83. PubMed ID: 16960925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional excretion magnesium (FE Mg) in systemic lupus erythematosus.
    Deekajorndech T
    J Med Assoc Thai; 2005 Jun; 88(6):743-5. PubMed ID: 16083212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal histopathologic alterations in patients treated with cyclosporine for uveitis.
    Palestine AG; Austin HA; Balow JE; Antonovych TT; Sabnis SG; Preuss HG; Nussenblatt RB
    N Engl J Med; 1986 May; 314(20):1293-8. PubMed ID: 3702930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease.
    Dong G; Panaro F; Bogetti D; Sammartino C; Rondelli D; Sankary H; Testa G; Benedetti E
    Clin Transplant; 2005 Feb; 19(1):56-60. PubMed ID: 15659135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function.
    Kallenberg CG; Schweitzer C; de Jong PE; Donker AJ; van der Hem GK
    Clin Nephrol; 1984 Nov; 22(5):223-9. PubMed ID: 6518673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study of renal hemodynamics in patients with lupus nephritis].
    Nakano M; Hasegawa H; Watanabe T; Kuroda T; Ito S; Saeki T; Ueno M; Ozawa T; Kikuchi M; Sato T
    Ryumachi; 1994 Aug; 34(4):725-32. PubMed ID: 7974023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of aminoglycoside nephrotoxicity in the dog.
    Cronin RE; Bulger RE; Southern P; Henrich WL
    J Lab Clin Med; 1980 Mar; 95(3):463-74. PubMed ID: 7354245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
    Svenson K; Bohman SO; Hällgren R
    Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
    Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S; Kobayashi Y; Shigematsu H; Hiki Y
    Q J Med; 1983; 52(207):311-31. PubMed ID: 6359226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.